Elevance Health (ELV) announced that John Gallina will retire from his role as executive vice president and CFO later this year. Mark Kaye has been named executive vice president and CFO and will serve as a member of the company’s executive leadership team, reporting directly to Gail Boudreaux, President and CEO. Kaye will serve as CFO Designate from September 6 to November 1, 2023, when he will assume full responsibility for the role. Gallina will remain with Elevance Health serving as Special Advisor to the CEO following his retirement as CFO to ensure a seamless transition. Kaye joins Elevance Health from Moody’s (MCO), where he served as CFO with responsibility for all global finance activities.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ELV:
- Elevance Health target raised to $585, named a ‘Top Pick’ at Morgan Stanley
- Elevance Health price target raised to $585 from $564 at TD Cowen
- Early notable gainers among liquid option names on July 19th
- Elevance (NYSE:ELV) Pops on Q2 Beat; Guidance Impresses
- Elevance Health reports Medical enrollment of 48M members